Healthy Clinical Trial
— VISIAOfficial title:
Surveillance of Suicide Ideation in Adolescents (VISIA)
Verified date | March 2024 |
Source | Servicio Gallego de Salud |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The goal of this observational study is to validate an AI algorithm's capability to differentiate the population with suicidal ideation from a control population using various multimodal variables, including voice analysis, facial emotions, natural language, and proteomics data. The primary research question it aims to answer is: Is it possible to identify suicidal ideation and suicide risk in adolescents early and non-intrusively using multimodal data analysis through digital instruments equipped with artificial intelligence? Participants in this study will be asked to: Complete psychometric instruments to establish a gold standard for detecting suicide risk and suicidal ideation. Provide voice recordings, facial emotion data, and linguistic content in natural and specific contexts. Participate in salivary proteomics data collection. This study compares three distinct groups: Ideation: Adolescent patients with current suicidal ideation. Clinical Population: Psychological or psychiatric patients of the same age and gender without suicidal ideation. General Population: Adolescents without known psychological or psychiatric pathology of the same age and gender, without suicidal ideation. Researchers will compare these groups to determine if the AI algorithm is effective in differentiating individuals with suicidal ideation (Group 1) from both a clinical control group (Group 2) and a general population control group (Group 3) using the collected multimodal data. The study aims to assess the algorithm's ability to identify early signs of suicide risk in these distinct participant populations.
Status | Enrolling by invitation |
Enrollment | 339 |
Est. completion date | November 24, 2024 |
Est. primary completion date | November 24, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 11 Years to 16 Years |
Eligibility | Inclusion Criteria: Ideation Group - Participants must be between 11 and 16 years old. - Patients who do not meet any of the exclusion criteria and whose parents (both), guardians, or legal representatives accept their voluntary participation in the study. In case of divorce, authorization from both parents will be required. - Patients receive care in child and adolescent psychiatry or psychology services and currently have suicidal ideation. - Patients may have a previous follow-up, as long as they have suicidal ideation at the present moment, or they may be new consultations and may be receiving pharmacological treatment (which will be documented in the study). Clinical Population Group - Participants must be between 11 and 16 years old. - Patients who do not meet any of the exclusion criteria and whose parents (both), guardians, or legal representatives accept their voluntary participation in the study. In case of divorce, authorization from both parents will be required. - Patients receive care in child and adolescent psychiatry or psychology services for any reason other than those listed as exclusion criteria. - Patients have not had suicidal ideation in the past year. Patients may have a previous follow-up or may be new consultations, and they may be receiving pharmacological treatment (which will be documented in the study). General Population Group - Participants must be between 11 and 16 years old. - Students who do not meet any of the exclusion criteria and whose parents (both), guardians, or legal representatives accept their voluntary participation in the study. In case of divorce, authorization from both parents will be required. - Students must declare that they have not received psychiatric or psychological follow-up before, nor have they had suicidal ideation in the past year. Exclusion Criteria (applicable to all groups): - Neurodevelopmental disorders or speech disorders affecting verbal communication capacity, specifically including: - Autism Spectrum Disorder grades 2 and 3. - Communication disorders (selective mutism, language disorder, phonological disorder, childhood-onset fluency disorder, social communication disorder). - Individuals with hearing impairment and verbal language impairment. - Individuals with moderate and severe intellectual disabilities. - Individuals with psychotic disorders. |
Country | Name | City | State |
---|---|---|---|
Spain | University Hospital Complex of Ourense | Ourense | |
Spain | Servizo Galego de Saúde | Santiago De Compostela | A Coruña |
Spain | Hospital Álvaro Cunqueiro | Vigo | Pontevedra |
Spain | University of Vigo | Vigo | Pontevedra |
Lead Sponsor | Collaborator |
---|---|
Servicio Gallego de Salud | Complejo Hospitalario Universitario de Vigo, Complexo Hospitalario de Ourense, Fundacin Biomedica Galicia Sur, University of Vigo |
Spain,
Abd-Alrazaq AA, Alajlani M, Alalwan AA, Bewick BM, Gardner P, Househ M. An overview of the features of chatbots in mental health: A scoping review. Int J Med Inform. 2019 Dec;132:103978. doi: 10.1016/j.ijmedinf.2019.103978. Epub 2019 Sep 25. — View Citation
Adamou M, Antoniou G, Greasidou E, Lagani V, Charonyktakis P, Tsamardinos I, Doyle M. Toward Automatic Risk Assessment to Support Suicide Prevention. Crisis. 2019 Jul;40(4):249-256. doi: 10.1027/0227-5910/a000561. Epub 2018 Nov 26. — View Citation
Bachmann S. Epidemiology of Suicide and the Psychiatric Perspective. Int J Environ Res Public Health. 2018 Jul 6;15(7):1425. doi: 10.3390/ijerph15071425. — View Citation
Briere J, Gil E. Self-mutilation in clinical and general population samples: prevalence, correlates, and functions. Am J Orthopsychiatry. 1998 Oct;68(4):609-20. doi: 10.1037/h0080369. — View Citation
Brunner R, Kaess M, Parzer P, Fischer G, Carli V, Hoven CW, Wasserman C, Sarchiapone M, Resch F, Apter A, Balazs J, Barzilay S, Bobes J, Corcoran P, Cosmanm D, Haring C, Iosuec M, Kahn JP, Keeley H, Meszaros G, Nemes B, Podlogar T, Postuvan V, Saiz PA, Sisask M, Tubiana A, Varnik A, Wasserman D. Life-time prevalence and psychosocial correlates of adolescent direct self-injurious behavior: a comparative study of findings in 11 European countries. J Child Psychol Psychiatry. 2014 Apr;55(4):337-48. doi: 10.1111/jcpp.12166. Epub 2013 Nov 12. — View Citation
Choi D, Sumner SA, Holland KM, Draper J, Murphy S, Bowen DA, Zwald M, Wang J, Law R, Taylor J, Konjeti C, De Choudhury M. Development of a Machine Learning Model Using Multiple, Heterogeneous Data Sources to Estimate Weekly US Suicide Fatalities. JAMA Netw Open. 2020 Dec 1;3(12):e2030932. doi: 10.1001/jamanetworkopen.2020.30932. — View Citation
Coppersmith G, Leary R, Crutchley P, Fine A. Natural Language Processing of Social Media as Screening for Suicide Risk. Biomed Inform Insights. 2018 Aug 27;10:1178222618792860. doi: 10.1177/1178222618792860. eCollection 2018. — View Citation
Czeisler ME, Lane RI, Petrosky E, Wiley JF, Christensen A, Njai R, Weaver MD, Robbins R, Facer-Childs ER, Barger LK, Czeisler CA, Howard ME, Rajaratnam SMW. Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic - United States, June 24-30, 2020. MMWR Morb Mortal Wkly Rep. 2020 Aug 14;69(32):1049-1057. doi: 10.15585/mmwr.mm6932a1. — View Citation
De Quiroga S, Riesgo M, Martín del Campo E, Pulido S, Rodrigo S. (2019) Impacto Socioeconómico de la depresión y el suicidio en España [Internet]. Rev Esp Econ Salud: 2019; 4(15).
Deveci A, Aydemir O, Taskin O, Taneli F, Esen-Danaci A. Serum BDNF levels in suicide attempters related to psychosocial stressors: a comparative study with depression. Neuropsychobiology. 2007;56(2-3):93-7. doi: 10.1159/000111539. Epub 2007 Nov 23. — View Citation
Fernandez-Martinez I, Morales A, Mendez FX, Espada JP, Orgiles M. Spanish Adaptation and Psychometric Properties of the Parent Version of the Short Mood and Feelings Questionnaire (SMFQ-P) in a Non-Clinical Sample of Young School-Aged Children. Span J Psychol. 2020 Nov 5;23:e45. doi: 10.1017/SJP.2020.47. — View Citation
Garcia de la Garza A, Blanco C, Olfson M, Wall MM. Identification of Suicide Attempt Risk Factors in a National US Survey Using Machine Learning. JAMA Psychiatry. 2021 Apr 1;78(4):398-406. doi: 10.1001/jamapsychiatry.2020.4165. — View Citation
Gillies D, Christou MA, Dixon AC, Featherston OJ, Rapti I, Garcia-Anguita A, Villasis-Keever M, Reebye P, Christou E, Al Kabir N, Christou PA. Prevalence and Characteristics of Self-Harm in Adolescents: Meta-Analyses of Community-Based Studies 1990-2015. J Am Acad Child Adolesc Psychiatry. 2018 Oct;57(10):733-741. doi: 10.1016/j.jaac.2018.06.018. Epub 2018 Aug 21. — View Citation
Golan O, Baron-Cohen S, Hill J. The Cambridge Mindreading (CAM) Face-Voice Battery: Testing complex emotion recognition in adults with and without Asperger syndrome. J Autism Dev Disord. 2006 Feb;36(2):169-83. doi: 10.1007/s10803-005-0057-y. — View Citation
Hawgood J, De Leo D. Suicide Prediction - A Shift in Paradigm Is Needed. Crisis. 2016 Jul;37(4):251-255. doi: 10.1027/0227-5910/a000440. No abstract available. — View Citation
Jacobson CM, Gould M. The epidemiology and phenomenology of non-suicidal self-injurious behavior among adolescents: a critical review of the literature. Arch Suicide Res. 2007;11(2):129-47. doi: 10.1080/13811110701247602. — View Citation
Johnston JN, Campbell D, Caruncho HJ, Henter ID, Ballard ED, Zarate CA. Suicide Biomarkers to Predict Risk, Classify Diagnostic Subtypes, and Identify Novel Therapeutic Targets: 5 Years of Promising Research. Int J Neuropsychopharmacol. 2022 Mar 17;25(3):197-214. doi: 10.1093/ijnp/pyab083. — View Citation
Kaess M, Parzer P, Haffner J, Steen R, Roos J, Klett M, Brunner R, Resch F. Explaining gender differences in non-fatal suicidal behaviour among adolescents: a population-based study. BMC Public Health. 2011 Jul 28;11:597. doi: 10.1186/1471-2458-11-597. — View Citation
Kamali M, Saunders EF, Prossin AR, Brucksch CB, Harrington GJ, Langenecker SA, McInnis MG. Associations between suicide attempts and elevated bedtime salivary cortisol levels in bipolar disorder. J Affect Disord. 2012 Feb;136(3):350-8. doi: 10.1016/j.jad.2011.11.027. Epub 2011 Dec 10. — View Citation
Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res. 2002 Mar 15;109(2):143-8. doi: 10.1016/s0165-1781(02)00005-7. — View Citation
Kouter K, Videtic Paska A. 'Omics' of suicidal behaviour: A path to personalised psychiatry. World J Psychiatry. 2021 Oct 19;11(10):774-790. doi: 10.5498/wjp.v11.i10.774. eCollection 2021 Oct 19. — View Citation
Krageloh CU, Czuba KJ, Billington DR, Kersten P, Siegert RJ. Using feedback from patient-reported outcome measures in mental health services: a scoping study and typology. Psychiatr Serv. 2015 Mar 1;66(3):224-41. doi: 10.1176/appi.ps.201400141. Epub 2014 Dec 1. — View Citation
Lo Moro G, Soneson E, Jones PB, Galante J. Establishing a Theory-Based Multi-Level Approach for Primary Prevention of Mental Disorders in Young People. Int J Environ Res Public Health. 2020 Dec 16;17(24):9445. doi: 10.3390/ijerph17249445. — View Citation
Meadows R, Hine C, Suddaby E. Conversational agents and the making of mental health recovery. Digit Health. 2020 Nov 20;6:2055207620966170. doi: 10.1177/2055207620966170. eCollection 2020 Jan-Dec. — View Citation
Miranda-Mendizabal A, Castellvi P, Pares-Badell O, Alayo I, Almenara J, Alonso I, Blasco MJ, Cebria A, Gabilondo A, Gili M, Lagares C, Piqueras JA, Rodriguez-Jimenez T, Rodriguez-Marin J, Roca M, Soto-Sanz V, Vilagut G, Alonso J. Gender differences in suicidal behavior in adolescents and young adults: systematic review and meta-analysis of longitudinal studies. Int J Public Health. 2019 Mar;64(2):265-283. doi: 10.1007/s00038-018-1196-1. Epub 2019 Jan 12. — View Citation
Navarro MC, Ouellet-Morin I, Geoffroy MC, Boivin M, Tremblay RE, Cote SM, Orri M. Machine Learning Assessment of Early Life Factors Predicting Suicide Attempt in Adolescence or Young Adulthood. JAMA Netw Open. 2021 Mar 1;4(3):e211450. doi: 10.1001/jamanetworkopen.2021.1450. — View Citation
Nock MK, Kazdin AE. Examination of affective, cognitive, and behavioral factors and suicide-related outcomes in children and young adolescents. J Clin Child Adolesc Psychol. 2002 Mar;31(1):48-58. doi: 10.1207/S15374424JCCP3101_07. — View Citation
Pacheco-Lorenzo MR, Valladares-Rodriguez SM, Anido-Rifon LE, Fernandez-Iglesias MJ. Smart conversational agents for the detection of neuropsychiatric disorders: A systematic review. J Biomed Inform. 2021 Jan;113:103632. doi: 10.1016/j.jbi.2020.103632. Epub 2020 Dec 2. — View Citation
Pandey GN, Dwivedi Y, Rizavi HS, Ren X, Zhang H, Pavuluri MN. Brain-derived neurotrophic factor gene and protein expression in pediatric and adult depressed subjects. Prog Neuropsychopharmacol Biol Psychiatry. 2010 May 30;34(4):645-51. doi: 10.1016/j.pnpbp.2010.03.003. Epub 2010 Mar 20. — View Citation
Parkhi O., Vedaldi A., and Zisserman A.. 2015. Deep Face Recognition. In Proceedings of the British Machine Vision Conference (BMVC). 41.1-41.12.
Pinon-Blanco A, Vergara-Moragues E, Fernandez-Martinez R, Gutierrez-Martinez O, Alvarez-Counago M, Martinez-Reglero C, Rivera-Baltanas T, Otero-Lamas F, Olivares-Diez J, Spuch-Calvar C. Effectiveness of the “Trisquel” board game intervention program for patients with schizophrenia spectrum disorders. Actas Esp Psiquiatr. 2020 Sep;48(5):209-219. Epub 2020 Sep 1. — View Citation
Ramirez-Cifuentes D, Freire A, Baeza-Yates R, Punti J, Medina-Bravo P, Velazquez DA, Gonfaus JM, Gonzalez J. Detection of Suicidal Ideation on Social Media: Multimodal, Relational, and Behavioral Analysis. J Med Internet Res. 2020 Jul 7;22(7):e17758. doi: 10.2196/17758. — View Citation
Rao ML, Hawellek B, Papassotiropoulos A, Deister A, Frahnert C. Upregulation of the platelet Serotonin2A receptor and low blood serotonin in suicidal psychiatric patients. Neuropsychobiology. 1998;38(2):84-9. doi: 10.1159/000026522. — View Citation
Rial Boubeta A, Gomez Salgado P, Isorna Folgar M, Araujo Gallego M, Varela Mallou J. PIUS-a: Problematic Internet Use Scale in adolescents. Development and psychometric validation. Adicciones. 2015 Mar 1;27(1):47-63. — View Citation
Roe D, Mazor Y, Gelkopf M. Patient-reported outcome measurements (PROMs) and provider assessment in mental health: a systematic review of the context of implementation. Int J Qual Health Care. 2021 Mar 5;34(Suppl 1):ii28-ii39. doi: 10.1093/intqhc/mzz084. Erratum In: Int J Qual Health Care. 2022 Mar 28;34(1): — View Citation
Rothe J, Buse J, Uhlmann A, Bluschke A, Roessner V. Changes in emotions and worries during the Covid-19 pandemic: an online-survey with children and adults with and without mental health conditions. Child Adolesc Psychiatry Ment Health. 2021 Feb 21;15(1):11. doi: 10.1186/s13034-021-00363-9. — View Citation
Spreux-Varoquaux O, Alvarez JC, Berlin I, Batista G, Despierre PG, Gilton A, Cremniter D. Differential abnormalities in plasma 5-HIAA and platelet serotonin concentrations in violent suicide attempters: relationships with impulsivity and depression. Life Sci. 2001 Jun 29;69(6):647-57. doi: 10.1016/s0024-3205(01)01158-4. — View Citation
Stappen, L., Baird, A., Christ, L., Schumann, L., Sertolli, B., Messner, E., Cambria, E., Zhao, G., Schuller, Björn. (2021). The MuSe 2021 Multimodal Sentiment Analysis Challenge: Sentiment, Emotion, Physiological-Emotion, and Stress.
Tsui FR, Shi L, Ruiz V, Ryan ND, Biernesser C, Iyengar S, Walsh CG, Brent DA. Natural language processing and machine learning of electronic health records for prediction of first-time suicide attempts. JAMIA Open. 2021 Mar 17;4(1):ooab011. doi: 10.1093/jamiaopen/ooab011. eCollection 2021 Jan. — View Citation
Vaidyam AN, Wisniewski H, Halamka JD, Kashavan MS, Torous JB. Chatbots and Conversational Agents in Mental Health: A Review of the Psychiatric Landscape. Can J Psychiatry. 2019 Jul;64(7):456-464. doi: 10.1177/0706743719828977. Epub 2019 Mar 21. — View Citation
Vallejo-Curto MDC, Rodrigues-Amorim D, Jardon-Golmar L, Blanco-Formoso M, Rivera-Baltanas T, Rodriguez-Jamardo C, Fernandez-Palleiro P, Alvarez-Ariza M, Lopez-Garcia M, Garcia-Caballero A, de Las Heras E, Olivares JM, Spuch C. Proteomic and metabolic profiling of chronic patients with schizophrenia induced by a physical activity program: Pilot study. Rev Psiquiatr Salud Ment (Engl Ed). 2021 Jul-Sep;14(3):125-138. doi: 10.1016/j.rpsmen.2021.07.002. Epub 2021 Aug 10. — View Citation
Vekiri I. and Chronaki A. (2008) "Gender issues in technology use: Perceived social support, computer self-efficacy and value beliefs, and computer use beyond school," Comput. Educ., vol. 51, no. 3, pp. 1392-1404, 2008.
Voss C, Ollmann TM, Miche M, Venz J, Hoyer J, Pieper L, Hofler M, Beesdo-Baum K. Prevalence, Onset, and Course of Suicidal Behavior Among Adolescents and Young Adults in Germany. JAMA Netw Open. 2019 Oct 2;2(10):e1914386. doi: 10.1001/jamanetworkopen.2019.14386. — View Citation
World Health Organisation (2021a) Comprehensive mental health action plan 2013-2030. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO.
World Health Organisation (2021b) Suicide in the world: global health estimates. 2019, 32 p., World Health Organization, Technical documents. WHO/MSD/MER/19.3.
World Health Organization (2014) Preventing suicide. A global imperative. Geneva: 2014.
Zhang Y, Zhang O, Wu Y, Lee HJ, Xu J, Xu H, Roberts K. Psychiatric symptom recognition without labeled data using distributional representations of phrases and on-line knowledge. J Biomed Inform. 2017 Nov;75S:S129-S137. doi: 10.1016/j.jbi.2017.06.014. Epub 2017 Jun 15. — View Citation
* Note: There are 47 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Oviedo Response Infrequency Scale-Revised (INF-OV-R) | Is a 10 items self-report measurement with a dichotomous response format (Yes/No) developed to detect those participants who respond randomly, pseudo-randomly, or dishonestly to the administered measuring instruments. The items on this scale are typically intermixed with questions and statements from other self-report measures that are administered together to o enable better detection. Higher values are indicative of random, pseudo-random, or dishonest answers. | through study completion, an average of 1 year | |
Primary | Strengths and Difficulties Questionnaire (SDQ) | This questionnaire detects probable cases of mental and behavioral disorders in children and adolescents aged 4 to 17. A score >19 points is considered positive in screening. | through study completion, an average of 1 year | |
Primary | Mood and Feelings Questionnaire (MFQ) | This questionnaire assesses symptoms of depression/suicide risk. Scores above 27 points are considered positive for screening. Higher values are indicative of worse outcomes. | through study completion, an average of 1 year | |
Primary | Paykel Suicide Scale (PSS) | This questionnaire asks about suicidal ideation over the past year. Scores equal to or greater than 4 are suggestive of suicidal ideation. Higher values are indicative of worse outcomes. | through study completion, an average of 1 year | |
Primary | Facial microexpressions, voice and linguistic content analysis | Participants will be asked to speak in front of a camera about their emotional state over the past week. The recording will have a minimum duration of 2 minutes and will be used for voice analysis, facial microexpressions, and natural language processing (NLP) for linguistic content analysis.
Participants will also be asked to write a brief text on the computer in response to questions about how they perceive themselves and how they think others perceive them. The maximum duration for this exercise is 10 minutes. |
through study completion, an average of 1 year | |
Primary | Proteomic and stress level analysis | The collection of saliva is performed in a simple, non-invasive, and painless manner, allowing for the subsequent retrieval of high-quality proteins for further analysis and studies. | through study completion, an average of 1 year | |
Secondary | Millon Adolescent Clinical Inventory - II (MACI-II) | A self-report questionnaire developed to evaluate the psychological functioning of adolescents. It assesses three domains in adolescent development. The average completion time is 30 minutes and can be conducted in groups. | through study completion, an average of 1 year | |
Secondary | Problematic Internet Use Scale in Adolescents (EUPI-A) | This 11-item questionnaire screens for problematic use of Internet among teenagers, ranginf fromm 0 to 44, with a cut-off for problematic use of 16 points. Higher values are indicative of worse outcomes. | through study completion, an average of 1 year | |
Secondary | European Bullying Intervention Project Questionnaire (EBIP-Q) and European Ciberbullying Intervention Project Questionnaire (ECIP-Q) | This tool for jointly assessing bullying and cyberbullying cointains The European Bullying Intervention Project Questionnaire (14-items) and the European Cyberbullying Intervention Project Questionnaire (22-items), both of Likert nature that respectively evaluate behaviors related to bullying and cyber-bullying. Higher values are indicative of worse outcomes. | through study completion, an average of 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |